What about St John’s wort?

The evidence belongs to extracts, not the plant name

The trials did not test every product labeled “St John’s wort.” They tested particular Hypericum extracts. Commercial products can differ in composition, dose, manufacturing quality, and how closely they resemble the preparations that produced the evidence.

That makes “Does St John’s wort work?” an incomplete question. The clinically useful question is whether a specific, evidence-linked extract can be used safely in a particular person’s care.

What the evidence earns

Across short-term trials, tested extracts performed better than placebo. Response rates did not differ materially from older antidepressants or selective serotonin reuptake inhibitors in the available direct comparisons, and fewer participants stopped the herbal treatment because of adverse effects.

This is a genuine efficacy signal, not supplement folklore. It is also mostly based on four-to-twelve-week studies of mild to moderately severe depression. The evidence is thinner for severe depression, long-term maintenance, and relapse prevention.

Many positive trials came from German-speaking countries. Whether that reflects differences in extracts, prescribing practices, study design, or other factors remains uncertain, so the results should be applied with appropriate caution elsewhere.

“Similar response” does not mean interchangeable care

The direct comparisons support similar short-term response rates in the studied populations. They do not prove exact equivalence, equal evidence across all outcomes, or suitability for severe depression.

They also do not show that any store product can replace a prescription antidepressant, psychotherapy, or medication monitoring. Current guidance gives St John’s wort an unusual seat among complementary options for milder depression while keeping established care above it as severity rises.

Why medication review is essential

St John’s wort can speed up the systems that process and transport many medicines, lowering their levels and making them less effective. Important examples include hormonal contraceptives and immunosuppressants.

Combining it with serotonergic medication can also increase the risk of serotonin toxicity. “Fewer people stopped because of side effects” does not cancel these concerns. Trial tolerability and drug-interaction safety answer different questions.

A full review must include prescriptions, over-the-counter medicines, and other supplements. Adding or stopping St John’s wort can change how another treatment behaves.

When the evidence best applies

The evidence fits best when all of these are present:

• milder major depression without an urgent safety need
• a standardized extract linked as closely as possible to the evidence
• a complete medication and supplement review
• shared discussion of alternatives and uncertainty
• follow-up with a clear plan for nonresponse, worsening, or adverse effects

Remove those parts and the claim becomes less secure, even if the bottle carries the same plant name.

Where it does not fit

St John’s wort should not become unsupervised add-on treatment to an antidepressant. It should not delay established care for moderate or severe depression, marked functional decline, or an immediate safety concern.

The evidence also does not establish it as long-term maintenance treatment or show that products can be switched by label alone.